home
stocks
stocks list
AstraZeneca Pharma Ind

AstraZeneca Pharma Ind Share Price

Q: What is the AstraZeneca Pharma Ind share price today?

AstraZeneca Pharma Ind share price is Rs. 6,939.65 today.

Q: What is today’s high & low stock price of AstraZeneca Pharma Ind?

AstraZeneca Pharma Ind stock price high: Rs. 7,085.00 and low: Rs. 6,888.00

Q: What is the market capital of AstraZeneca Pharma Ind shares today?

AstraZeneca Pharma Ind has a market capitalization of Rs. 17,669.00 Crores.

Q: What is the AstraZeneca Pharma Ind stock price high and low in the last 52 weeks on the NSE?

52 Week Stock High Price is Rs. 7,572.20 and Low Price is Rs. 3,750.00

Q: What is the AstraZeneca Pharma Ind Stock Symbol?

The AstraZeneca Pharma Ind Stock symbol is ASTRAZEN.

Q: Can I buy AstraZeneca Pharma Ind shares on Holidays?

<div class="text-sm text-gray-accent3">No, shares of AstraZeneca Pharma Ind or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell AstraZeneca Pharma Ind shares on days when the stock exchanges are open for trading. It's important to check the <a class="text-primary-base" target="_blank" href="https://upstox.com/stocks-market/nse-holidays-2024/">NSE</a> & <a class="text-primary-base" target="_blank" href="https://upstox.com/stocks-market/bse-holidays-2024/">BSE</a> holidays calendar, before placing any trades to avoid any inconvenience.</div>

Q: Can I do stock trading on my phone?

<div class="text-sm text-gray-accent3">Yes, Upstox trading app allows you to trade easily once KYC documents are verified online. This app is available for both iOS and Android devices. For the Android app, <a class="text-primary-base" target="_blank" href="https://play.google.com/store/apps/details?id=in.upstox.app&pli=1">click here</a>, and for the iOS app, <a class="text-primary-base" target="_blank" href="https://apps.apple.com/in/app/upstox-stocks-ipo-mf/id1584953620">click here</a>.</div>

ASTRAZEN

₹6,939.65-₹142.05 (-2.01%) TodayLast updated on 25 Jul, 2024 | 15:41 IST

₹6,888.00₹7,085.00

News
Company overview
Fundamentals
Events
More

What’s in news?

Livemint • 1d

Stocks to buy or sell: Gravita India to NIIT — Sumeet Bagadia recommends

ET • 2w

What should investors do with Raymond, RBL Bank and AstraZeneca India?

Livemint • 2w

Stocks to buy or sell: NELCO to MBL Infrastructure — Sumeet Bagadia

Moneycontrol • 3w

AstraZeneca to invest Rs 250 crore for GCC expansion in Chennai

Upstox • 1mo

AstraZeneca Pharma India reports 129% rise in Q4 PAT at ₹39.47 crore, operating revenue up 35%

Moneycontrol • 1mo

AstraZeneca Pharma Standalone March 2024 Net Sales at Rs 383.20 crore

Moneycontrol • 1mo

Astrazeneca India Q4 net profit jumps 128% to Rs 39 crore

CNBC • 1mo

Dividend shares: AstraZeneca Pharma India to pay ₹24 final dividend

DSIJ • 1mo

Volume shockers: Top 5 stocks from Nifty 500 attracted heavy volumes

Livemint • 2mo

London FTSE 100 hits record high on AstraZeneca COVID-19 vaccine withdrawal

Company overview

Financial performance

Market cap

₹17,669 Crs

Open

₹6,939.90

Close

₹7,081.70

Circuit range

₹8,498.00 - ₹5,665.40

Day range

₹6,888.00 - ₹7,085.00

Year range

₹3,750.00 - ₹7,572.20

Volume

22,659

Avg. traded

₹6,990.79

Revenue (12m)

₹1,296 Crs

AstraZeneca Pharma IndAstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).

AstraZeneca Pharma Ind Key indicators

52 week high

₹7,572.20

52 week low

₹3,750.00

P/E ratio

109.4 P/B ratio

22.4 ROE

24.95%

ROCE

33.94%

Dividend yield

0.38%

Debt/Equity ratio

EPS

64.6

Learn more

Featured in

Pharmaceuticals

Investment checklist: (5/6)

Equity returns

Dividend returns

Safety factor

Growth factor

Debt vs Equity

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

Profitability
Operational
Valuation

Operating profit margin

16.84%

Net profit margin

12.4%

ROE

24.95%

ROA

13.35%

ROCE

33.94%

Learn more

AstraZeneca Pharma Ind Shareholder returns

1 day

+0.20%

1 week

+7.86%

1 month

+12.10%

3 months

+34.00%

1 year

+87.84%

3 years

+102.45%

5 years

+282.17%

AstraZeneca Pharma Ind Share Price history

Day	Open	Close	Day’s change
Wed, Jul 24 2024	₹7,099.70	₹7,081.70	+0.20%
Tue, Jul 23 2024	₹6,249.80	₹7,067.60	+13.13%
Mon, Jul 22 2024	₹6,289.05	₹6,247.05	-1.59%
Fri, Jul 19 2024	₹6,469.80	₹6,347.80	-1.62%
Thu, Jul 18 2024	₹6,565.80	₹6,452.05	-1.73%
Tue, Jul 16 2024	₹6,610.70	₹6,565.80	-0.68%
Mon, Jul 15 2024	₹6,750.20	₹6,610.75	-2.07%
Fri, Jul 12 2024	₹6,878.35	₹6,750.25	-1.86%

Shareholding info

Promoters (75%)	Mutual Funds (4.97%)	Retail and other (17.21%)
Foreign institutions-FII (2.79%)	Other domestic institutions (0.03%)

Promoters

Learn more

Events

Corporate actions

Dividend • ₹24/share
Ex date 05 Jul 2024
Dividend • ₹16/share
Ex date 14 Jul 2023
Dividend • ₹8/share
Ex date 07 Jul 2022

Dividend₹24 per share

Dividend

₹24 per share

Announcement date

27 May 2024

Ex dividend date

05 Jul 2024

Record date

05 Jul 2024

Dividend type

Final

Amount

₹24.0

Dividend %

1200.0%

Learn more

Similar stocks

Granules India

₹550.90

+₹12.95 (2.41%)

Jubilant Ingrevia

₹590.95

+₹5.80 (0.99%)

Procter & Gamble Health

₹5,275.00

+₹46.65 (0.89%)

Jubilant Pharmova

₹731.65

+₹8.75 (1.21%)

Eris Lifesciences

₹1,067.00

+₹18.30 (1.75%)

Aarti Drugs

₹525.60

-₹4.75 (-0.9%)

FDC Limited

₹507.90

+₹1.90 (0.38%)

Caplin Point Lab

₹1,505.00

-₹15.75 (-1.04%)

Hikal

₹353.30

-₹10.60 (-2.91%)

Glenmark Life Science

₹876.25

+₹22.45 (2.63%)

People also bought

Indian Railway Tourism Corp

₹969.15

-₹5.05 (-0.52%)

YES Bank

₹24.62

-₹0.28 (-1.12%)

Tata Motors

₹1,090.95

+₹63.25 (6.15%)

HDFC Bank

₹1,616.60

+₹12.55 (0.78%)

Tata Power

₹423.35

+₹3.40 (0.81%)

Infosys

₹1,824.85

-₹9.10 (-0.5%)

Tata Consultancy Services

₹4,322.50

+₹16.25 (0.38%)

Reliance Industries

₹2,984.80

-₹6.60 (-0.22%)

Hindustan Unilever

₹2,707.20

-₹9.85 (-0.36%)

Amara Raja Batteries

₹1,565.80

-₹7.90 (-0.5%)

Key indices

Nifty 50

Nifty Next 50

Nifty Bank

Nifty 100

Nifty 200

Nifty 500

Nifty Midcap 50

NIFTY SMLCAP 50

India VIX

AstraZeneca Pharma Ind Share Price

News

Company overview

Fundamentals

Events

More

What’s in news?

Company overview

Financial performance

Market cap

₹17,669 Crs

Open

₹6,939.90

Close

₹7,081.70

Circuit range

₹8,498.00 - ₹5,665.40

Day range

₹6,888.00 - ₹7,085.00

Year range

₹3,750.00 - ₹7,572.20

Volume

22,659

Avg. traded

₹6,990.79

Revenue (12m)

₹1,296 Crs

AstraZeneca Pharma Ind Key indicators

52 week high

₹7,572.20

52 week low

₹3,750.00

P/E ratio

109.4

P/B ratio

22.4

ROE

24.95%

ROCE

33.94%

Dividend yield

0.38%

Debt/Equity ratio

EPS

64.6

Featured in

Investment checklist: (5/6)

Fundamentals

Financial ratios

Profitability

Operational

Valuation

Operating profit margin

16.84%

Net profit margin

12.4%

ROE

24.95%

ROA

13.35%

ROCE

33.94%

AstraZeneca Pharma Ind Shareholder returns

1 day

+0.20%

1 week

+7.86%

1 month

+12.10%

3 months

+34.00%

1 year

+87.84%

3 years

+102.45%

5 years

+282.17%

AstraZeneca Pharma Ind Share Price history

Shareholding info

Events